P1102: A PHASE 1 STUDY OF PARSACLISIB IN COMBINATION WITH RITUXIMAB, BENDAMUSTINE + RITUXIMAB, OR IBRUTINIB IN PATIENTS WITH PREVIOUSLY TREATED B‐CELL LYMPHOMA (CITADEL‐112): PRELIMINARY SAFETY RESULTS

Saved in:
Bibliographic Details
Published inHemaSphere Vol. 6; no. Suppl; pp. 992 - 993
Main Authors Sancho, J.‐M., Lopez‐Guillermo, A., Abrisqueta, P., Kumar, A., Cordoba, R., Tani, M., Zhao, W., Rappold, E., Langmuir, P., Mims, M.
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Lippincott Williams & Wilkins 23.06.2022
Wiley
Online AccessGet full text

Cover

More Information
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000847276.06711.b7